Crescendo Biologics Appoints Matthew Roe as Chief Business Officer

Crescendo Biologics

Cambridge, UK. 22 June 2011 – Crescendo Biologics Limited (Crescendo) today announces the appointment of Matthew Roe as Chief Business Officer. Matthew joins Crescendo from Genzyme Corporation where he was Senior Director, Business Development & Licensing. During a 23-year career at Genzyme, Matthew was active in licensing, alliance management, acquisition, divestment, and sales and marketing, and saw the corporation develop from an entrepreneurial start-up to a leading multi-national biotechnology company. He negotiated and managed multiple agreements for drug delivery technologies in the USA, Europe and Japan and was also a core team member on the divestment of Genzyme’s Pharmaceuticals business. Mike Romanos, CEO of Crescendo said: “Matthew’s track record in business development speaks for itself. He has an exceptional depth of experience in business strategy and in implementing agreements across multiple territories. I look forward to working with him as we build on the significant advances we have made at Crescendo and position the Company to deliver real value from its world class, proprietary technology platforms.” Matthew Roe, CBO of Crescendo said: “The monoclonal antibody market is rapidly growing and continues to be a major focus for the pharma industry. Companies are searching for new platforms and approaches, particularly in the area of antibody fragments. Crescendo’s technology platform, IP and insight create a strong foundation from which to make a significant impact in the field and I am delighted to be joining the Company’s management team as it seeks to grow to become a leader in next-generation antibody therapeutics.”

More News

P2i Demonstrates Magical Protective Liquid Repellent Nano-Coating For Smartphones At...

Just one drop of liquid can destroy your phone or tablet! Acting like a...

read more

Mike Romanos Appointed CEO Of Crescendo Biologics

UK. 12 October 2009 – Mike Romanos has been appointed Chief Scientific Officer of...

read more